Ikarian Capital »

Fusion Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8M 500k 9.61

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Fusion Pharmaceuticals

Federated Investors
Avidity Partners Management
Deerfield Management Company
OrbiMed Advisors
Perceptive Advisors
Tpg Gp A
Sphera Funds Management
Artal Group
William Blair $ Company
Wellington Management Company
Eagle Health Investments
Millennium Management
Ikarian Capital
Marshall Wace
Fred Alger Management

View all funds holding Fusion Pharmaceuticals